| 113.38 Real-Time Quote | +1.18 / +1.05%Today’s Change | 58.53 Today|||52-Week Range 131.82 | +44.49% Year-to-Date |
The 24 analysts offering 12-month price forecasts for Celgene Corp have a median target of 142.00, with a high estimate of 152.00 and a low estimate of 95.22. The median estimate represents a +25.24% increase from the last price of 113.38.

The current consensus among 31 polled investment analysts is to Buy stock in Celgene Corp. This rating has held steady since May, when it was unchanged from a rating.Move your mouse over past
months for detail

Move your mouse over a quarter or year to see how estimates have changed over time.




